metformin
CONCLUSIONS: There was evidence of over-utilization       of metformin and glibenclamide in type 2 diabetes patients most at risk of       adverse reactions.
CONCLUSIONS: There was evidence of over-utilization       of  @SUBJECT$  and glibenclamide  @PREDICAT$   @OBJECT$  patients most at risk of       adverse reactions.